(AXON) Axon Enterprise - Overview
Stock: Body Cameras, Car Cameras, Tasers, Cloud Software
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 79.6% |
| Relative Tail Risk | -22.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.69 |
| Alpha | -56.41 |
| Character TTM | |
|---|---|
| Beta | 1.142 |
| Beta Downside | 1.039 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.11% |
| CAGR/Max DD | 0.58 |
Description: AXON Axon Enterprise January 28, 2026
Axon Enterprise, Inc. (NASDAQ: AXON) delivers integrated public-safety technology, split between a Software & Sensors segment that sells body-cameras, in-car cameras, cloud-based evidence-management platforms, and related services, and a TASER segment that manufactures conducted-energy weapons, accessories, and VR-based training solutions. The firm serves law-enforcement agencies, fire and EMS departments, corrections, and a growing consumer market through direct online sales and distribution partners, building on its rebranding from TASER International in 2017.
Recent quarterly data (Q4 2025) show total revenue of $1.12 billion, a 14 % year-over-year increase driven primarily by a 22 % rise in subscription-based evidence-management ARR. Operating margin expanded to 18 % as the company leveraged higher-margin software contracts, while the TASER hardware segment grew 8 % on renewed procurement cycles. Macro-level, U.S. public-safety capital-expenditure is projected to rise 4 % annually through 2028, and state-level mandates for body-camera adoption continue to lift demand for Axon’s integrated hardware-software bundles.
For a deeper, data-rich valuation perspective, consider exploring Axon’s profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 257.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -3.32 > 1.0 |
| NWC/Revenue: 112.1% < 20% (prev 83.11%; Δ 28.97% < -1%) |
| CFO/TA 0.04 > 3% & CFO 244.3m > Net Income 257.1m |
| Net Debt (678.2m) to EBITDA (310.9m): 2.18 < 3 |
| Current Ratio: 3.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (78.4m) vs 12m ago 0.43% < -2% |
| Gross Margin: 60.31% > 18% (prev 0.60%; Δ 5971 % > 0.5%) |
| Asset Turnover: 47.98% > 50% (prev 48.38%; Δ -0.40% > 0%) |
| Interest Coverage Ratio: 3.52 > 6 (EBITDA TTM 310.9m / Interest Expense TTM 67.2m) |
Altman Z'' 3.85
| A: 0.43 (Total Current Assets 4.22b - Total Current Liabilities 1.35b) / Total Assets 6.66b |
| B: 0.14 (Retained Earnings 933.9m / Total Assets 6.66b) |
| C: 0.04 (EBIT TTM 237.0m / Avg Total Assets 5.33b) |
| D: 0.25 (Book Value of Equity 921.4m / Total Liabilities 3.63b) |
| Altman-Z'' Score: 3.85 = AA |
Beneish M -3.15
| DSRI: 0.60 (Receivables 700.7m/885.6m, Revenue 2.56b/1.94b) |
| GMI: 0.99 (GM 60.31% / 59.84%) |
| AQI: 0.97 (AQ_t 0.32 / AQ_t-1 0.33) |
| SGI: 1.32 (Revenue 2.56b / 1.94b) |
| TATA: 0.00 (NI 257.1m - CFO 244.3m) / TA 6.66b) |
| Beneish M-Score: -3.15 (Cap -4..+1) = AA |
What is the price of AXON shares?
Over the past week, the price has changed by -14.35%, over one month by -33.90%, over three months by -29.45% and over the past year by -38.85%.
Is AXON a buy, sell or hold?
- StrongBuy: 7
- Buy: 7
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AXON price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 815 | 96.8% |
| Analysts Target Price | 815 | 96.8% |
| ValueRay Target Price | 505.5 | 22% |
AXON Fundamental Data Overview February 05, 2026
P/E Forward = 57.4713
P/S = 14.0148
P/B = 11.8402
P/EG = 2.86
Revenue TTM = 2.56b USD
EBIT TTM = 237.0m USD
EBITDA TTM = 310.9m USD
Long Term Debt = 1.73b USD (from longTermDebt, last quarter)
Short Term Debt = 279.6m USD (from shortTermDebt, last quarter)
Debt = 2.10b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 678.2m USD (from netDebt column, last quarter)
Enterprise Value = 35.57b USD (35.85b + Debt 2.10b - CCE 2.38b)
Interest Coverage Ratio = 3.52 (Ebit TTM 237.0m / Interest Expense TTM 67.2m)
EV/FCF = 245.3x (Enterprise Value 35.57b / FCF TTM 145.0m)
FCF Yield = 0.41% (FCF TTM 145.0m / Enterprise Value 35.57b)
FCF Margin = 5.67% (FCF TTM 145.0m / Revenue TTM 2.56b)
Net Margin = 10.05% (Net Income TTM 257.1m / Revenue TTM 2.56b)
Gross Margin = 60.31% ((Revenue TTM 2.56b - Cost of Revenue TTM 1.02b) / Revenue TTM)
Gross Margin QoQ = 60.14% (prev 60.39%)
Tobins Q-Ratio = 5.34 (Enterprise Value 35.57b / Total Assets 6.66b)
Interest Expense / Debt = 1.38% (Interest Expense 28.9m / Debt 2.10b)
Taxrate = 1.17% (4.47m / 381.5m)
NOPAT = 234.2m (EBIT 237.0m * (1 - 1.17%))
Current Ratio = 3.12 (Total Current Assets 4.22b / Total Current Liabilities 1.35b)
Debt / Equity = 0.69 (Debt 2.10b / totalStockholderEquity, last quarter 3.03b)
Debt / EBITDA = 2.18 (Net Debt 678.2m / EBITDA 310.9m)
Debt / FCF = 4.68 (Net Debt 678.2m / FCF TTM 145.0m)
Total Stockholder Equity = 2.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.82% (Net Income 257.1m / Total Assets 6.66b)
RoE = 9.66% (Net Income TTM 257.1m / Total Stockholder Equity 2.66b)
RoCE = 5.40% (EBIT 237.0m / Capital Employed (Equity 2.66b + L.T.Debt 1.73b))
RoIC = 5.40% (NOPAT 234.2m / Invested Capital 4.34b)
WACC = 9.63% (E(35.85b)/V(37.95b) * Re(10.12%) + D(2.10b)/V(37.95b) * Rd(1.38%) * (1-Tc(0.01)))
Discount Rate = 10.12% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.46%
[DCF Debug] Terminal Value 76.14% ; FCFF base≈175.1m ; Y1≈216.0m ; Y5≈367.8m
Fair Price DCF = 50.12 (EV 4.66b - Net Debt 678.2m = Equity 3.98b / Shares 79.4m; r=9.63% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 39.00 | EPS CAGR: -35.02% | SUE: -4.0 | # QB: 0
Revenue Correlation: 99.32 | Revenue CAGR: 37.11% | SUE: 0.83 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.59 | Chg30d=-0.002 | Revisions Net=-1 | Analysts=15
EPS next Year (2026-12-31): EPS=7.54 | Chg30d=-0.003 | Revisions Net=-1 | Growth EPS=+19.4% | Growth Revenue=+25.6%